Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure
Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure have?
Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure has 16 citations in the OpenAlex counts ScholarIQ stores.
When was Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure published?
Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure has 2017 year in the ScholarIQ index.
What is the open-access status of Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure?
Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure has closed oa status in the ScholarIQ index.
What is the DOI of Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure?
The DOI for Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure is on the source record.
What is the PMID of Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure?
The PMID for Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure is on the source record.
What is the OpenAlex record for Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure?
The OpenAlex for Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure is on the source record.